Ren Xiu-Rong, Reiter Eric, Ahn Seungkirl, Kim Jihee, Chen Wei, Lefkowitz Robert J
Department of Biochemistry, Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA.
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1448-53. doi: 10.1073/pnas.0409534102. Epub 2005 Jan 25.
Signaling through beta-arrestins is a recently appreciated mechanism used by seven-transmembrane receptors. Because G protein-coupled receptor kinase (GRK) phosphorylation of such receptors is generally a prerequisite for beta-arrestin binding, we studied the roles of different GRKs in promoting beta-arrestin-mediated extracellular signal-regulated kinase (ERK) activation by a typical seven-transmembrane receptor, the Gs-coupled V2 vasopressin receptor. Gs- and beta-arrestin-mediated pathways to ERK activation could be distinguished with H89, an inhibitor of protein kinase A, and beta-arrestin 2 small interfering RNA, respectively. The roles of GRK2, -3, -5, and -6 were assessed by suppressing their expression with specific small interfering RNA sequences. By using this approach, we demonstrated that GRK2 and -3 are responsible for most of the agonist-dependent receptor phosphorylation, desensitization, and recruitment of beta-arrestins. In contrast, GRK5 and -6 mediated much less receptor phosphorylation and beta-arrestin recruitment, but yet appeared exclusively to support beta-arrestin 2-mediated ERK activation. GRK2 suppression actually increased beta-arrestin-stimulated ERK activation. These results suggest that beta-arrestin recruited in response to receptor phosphorylation by different GRKs has distinct functional potentials.
通过β-抑制蛋白的信号传导是七跨膜受体最近才被认识到的一种机制。由于此类受体的G蛋白偶联受体激酶(GRK)磷酸化通常是β-抑制蛋白结合的先决条件,我们研究了不同GRK在促进典型的七跨膜受体(Gs偶联的V2血管加压素受体)介导的β-抑制蛋白介导的细胞外信号调节激酶(ERK)激活中的作用。蛋白激酶A的抑制剂H89和β-抑制蛋白2小干扰RNA可分别区分Gs和β-抑制蛋白介导的ERK激活途径。通过用特定的小干扰RNA序列抑制GRK2、-3、-5和-6的表达来评估它们的作用。通过使用这种方法,我们证明GRK2和-3负责大部分激动剂依赖性受体磷酸化、脱敏以及β-抑制蛋白的募集。相比之下,GRK5和-6介导的受体磷酸化和β-抑制蛋白募集要少得多,但似乎专门支持β-抑制蛋白2介导的ERK激活。抑制GRK2实际上增加了β-抑制蛋白刺激的ERK激活。这些结果表明,由不同GRK响应受体磷酸化而募集的β-抑制蛋白具有不同的功能潜力。